Here, we hypothesized that SFA such as PA is increased in asthma patients with obesity, which exacerbates type 2 airway inflammation in part by modulating IL-13-mediated release of soluble dipeptidyl peptidase 4 (DPP4). Here, DPP4 is linked to asthma.